Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07615829

Health Benefits of Dance Exercise

In Greece, people of different age groups, including young children to older adults, participate in dance exercise training. Although it is well-known that regular participation in dancing is associated with benefits such as entertainment, socialization and increased physical activity, the long-term effects of dancing on metabolic and mental health as well as physical performance remain largely unknown. Therefore, the aim of this study is to investigate the effects of a 6-month dancing exercise intervention on metabolic and mental health and physical performance in premenopausal and postmenopausal women.

Recruiting

Interested in participating?

Request Info

Key information

Age range

35 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Twenty premenopausal and twenty postmenopausal inactive women meeting the inclusion criteria will be randomly assigned to a Control (n=20) or an Experimental group (n=20). The Control group will maintain their habitual physical activity level without participating in any form of exercise training. The Experimental group will participate in two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching). Heart rate will be continuously monitored during each session by using heart rate monitors while the rate of perceived exertion (RPE) will be recorded at the end of each session. In addition, prior to the second dance exercise session in each week, participants' delayed onset of muscle soreness (DOMS) and wellness status (through the wellness report) will be evaluated. Prior to (Baseline) and after the intervention period (at 6 months) participants of both groups (Control and Experimental) will undergo resting blood sampling and assessment of their (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level, (v) dietary intake, (vi) quality of life and (vii) mental health.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Free of musculoskeletal injuries
  • Free of chronic non-communicable diseases
  • Normal menstrual cycle (for premenopausal women)
  • No recent childbirth (previous 12 months) (for premenopausal women)
  • At least 12 months since the oncet of menopause (for postmenopausal women)
  • Non smokers

Exclusion criteria

  • Pregnancy (for premenopausal women)
  • Contraindications to exercise training
  • Illness or other medical condition
  • Use of medication

Treatment and study plan

Exercise training

Other

This intervention will consist of two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching)

No exercise training

Other

It will include only habitual physical activity level without participating in any form of exercise training

Primary outcomes

  1. Change in glucose concentration

    Time frame: At baseline and 6 months

    Fasting glucose concentration will be determined in blood

  2. Change in insulin concentration

    Time frame: At baseline and 6 months

    Fasting insulin concentration will be determined in blood

  3. Change in total cholesterol concentration

    Time frame: At baseline and 6 months

    Total cholesterol concentration will be determined in blood

  4. Change in HDL cholesterol concentration

    Time frame: At baseline and 6 months

    HDL cholesterol concentration will be determined in blood

  5. Change in LDL cholesterol concentration

    Time frame: At baseline and 6 months

    LDL cholesterol concentration will be determined in blood

  6. Change in triglycerides concentration

    Time frame: At baseline and 6 months

    Triglycerides concentration will be determined in blood

  7. Change in serum glutamic-oxaloacetic transaminase (SGOT/AST) concentration

    Time frame: At baseline and 6 months

    SGOT concentration will be determined in blood

  8. Change in alanine aminotransferase (SGPT/ALT) concentration

    Time frame: At baseline and 6 months

    SGPT concentration will be determined in blood

  9. Change in gamma-glutamyl transpeptidase (γ-GT) concentration

    Time frame: At baseline and 6 months

    γ-GT concentration will be determined in blood

  10. Change in body weight

    Time frame: At baseline and 6 months

  11. Change in waist circumference

    Time frame: At baseline and 6 months

  12. Change in hip circumference

    Time frame: At baseline and 6 months

  13. Change in fat mass

    Time frame: At baseline and 6 months

    Fat mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)

  14. Change in body fat percentage (%)

    Time frame: At baseline and 6 months

    Body fat percentage (%) will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)

  15. Change in fat free mass

    Time frame: At baseline and 6 months

    Fat free mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)

  16. Change in lean body mass

    Time frame: At baseline and 6 months

    Lean body mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)

  17. Change in cardiorespiratory fitness

    Time frame: At baseline and 6 months

    Cardiorespiratory fitness will be assessed using the Ebbeling single stage treadmill test

  18. Change in functional performance

    Time frame: At baseline and 6 months

    Functional performance will be assessed using the Short Physical Performance Battery

  19. Change in muscle endurance

    Time frame: At baseline and 6 months

    Muscle endurance will be assessed using the push-up and curl-up testing protocols

  20. Change in resting blood pressure

    Time frame: At baseline and 6 months

    Resting systolic and diastolic blood pressure will be assessed using a sphygmomanometer

  21. Change in quality of life

    Time frame: At baseline and 6 months

    Quality of life will be evaluated using questionnaire

  22. Change in vitality

    Time frame: At baseline and 6 months

    Vitality will be evaluated using questionnaire

  23. Change in anxiety level

    Time frame: At baseline and 6 months

    Anxiety will be evaluated using questionnaire

  24. Change in flourishing

    Time frame: At baseline and 6 months

    Flourishing will be evaluated using questionnaire

Secondary outcomes

  1. Change in dietary intake

    Time frame: At baseline and 6 months

    Dietary intake will be monitored using diet recalls

  2. Change in daily number of steps

    Time frame: At baseline and 6 months

    Daily number of steps performed will be assessed using accelerometers

  3. Change in daily time spent in moderate-to-vigorous physical activity

    Time frame: At baseline and 6 months

    The time spent in moderate-to-vigorous physical activity will be assessed using accelerometers

Study contacts

Contact information is provided by the study sponsor or research team.

Dimitrios Draganidis, PhD

CONTACT

[email protected]

+30 2431047047

Ioannis G Fatouros, PhD

CONTACT

[email protected]

+ 30 2431047047

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Official study title

Effects of a 6-month Dance Exercise Intervention on Physical Performance, Metabolic and Mental Health in Pre- and Post-menopausal Women

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 29, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.